23andMe Holding (ME)

Company Profile

23andme is the leading personal genetics company dedicated to helping individuals understand their own genetic information through dna analysis technologies and web-based interactive tools. the company's personal genome service® enables individuals to gain deeper insights into their ancestry and genetic make-up. the vision for 23andme is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andme was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science.

Company profile

Ticker

Exchange

Website

Incorporated

Location

Fiscal year end

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Bausch Health Companies • Celgene ...

Former names

Bleecker Street Acquisition Corp., VG Acquisition Corp.

SEC CIK

0001804591

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

23andMe, Inc. • Lemonaid Health Inc. • Lemonaid Health Limited ...

ME stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

8-K/A

Regulation FD Disclosure

1 Dec 23

8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

13 Nov 23

8-K

23andMe Reports Second Quarter Fiscal 2024 Financial Results

8 Nov 23

23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

6 Nov 23

8-K

23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK

30 Oct 23

8-K

Departure of Directors or Certain Officers

27 Oct 23

8-K

Regulation FD Disclosure

10 Oct 23

8-K

Departure of Directors or Certain Officers

19 Sep 23

S-8

Registration of securities for employees

15 Sep 23

Transcripts

View all

Earnings call transcript

2024 Q2

8 Nov 23

Earnings call transcript

2024 Q1

8 Aug 23

Earnings call transcript

2023 Q4

25 May 23

Earnings call transcript

2023 Q3

8 Feb 23

Earnings call transcript

2023 Q2

8 Nov 22

Earnings call transcript

2023 Q1

9 Aug 22

Earnings call transcript

2022 Q4

27 May 22

Earnings call transcript

2022 Q3

11 Feb 22

Earnings call transcript

2021 Q2

11 Nov 21

Earnings call transcript

2022 Q1

13 Aug 21

Latest ownership filings

View all

KATHY L HIBBS

1 Dec 23

144

Notice of proposed sale of securities

Joseph Anthony Selsavage

Notice of proposed sale of securities

Notice of proposed sale of securities

19 Oct 23

Financial summary

Financial statements Chart ME financial data

Quarter (USD)	Sep 23	Jun 23	Mar 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Mar 23	Mar 22	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	264.76 mm	264.76 mm	264.76 mm	264.76 mm	264.76 mm	264.76 mm
Cash burn (monthly)	19.32 mm	12.89 mm	26.38 mm	29.56 mm	19.04 mm	12.16 mm
Cash used (since last report)	44.76 mm	29.86 mm	61.10 mm	68.49 mm	44.11 mm	28.16 mm
Cash remaining	220.00 mm	234.89 mm	203.66 mm	196.27 mm	220.65 mm	236.60 mm
Runway (months of cash)	11.4	18.2	7.7	6.6	11.6	19.5

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2023

ME institutional ownership history Ownership history

93.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	169	173	-2.3%
Opened positions	15	30	-50.0%
Closed positions	19	26	-26.9%
Increased positions	60	45	+33.3%
Reduced positions	37	46	-19.6%

13F shares	Current	Prev Q	Change
Total value	131.88 bn	232.58 bn	-43.3%
Total shares	291.31 mm	291.13 mm	+0.1%
Total puts	223.30 k	252.30 k	-11.5%
Total calls	502.60 k	725.30 k	-30.7%
Total put/call ratio	0.4	0.3	+27.7%

Largest owners	Shares	Value	Change
ABeeC 2.0	98.63 mm	$1.08 bn	0.0%
GSK GSK	39.66 mm	$116.21 mm	0.0%
Vanguard	28.15 mm	$27.52 bn	+3.1%
BLK Blackrock	19.60 mm	$19.16 bn	+1.4%
NewView Capital Partners I	19.46 mm	$19.07 bn	0.0%
NewView Capital Fund I	19.46 mm	$0.00	0.0%
Euclidean Capital	10.24 mm	$10.01 bn	0.0%
FMR	6.70 mm	$6.55 bn	-4.5%
STT State Street	6.61 mm	$6.47 bn	+7.0%
Geode Capital Management	6.12 mm	$5.99 bn	+9.0%

Largest transactions	Shares	Bought/sold	Change
MS Morgan Stanley	934.02 k	-1.49 mm	-61.5%
Two Sigma Investments	172.13 k	-936.51 k	-84.5%
Vanguard	28.15 mm	+834.50 k	+3.1%
Voya Investment Management	2.43 mm	+778.45 k	+47.1%
Balyasny Asset Management	0.00	-600.00 k	EXIT
Millennium Management	0.00	-575.15 k	EXIT
Wittenberg Investment Management	1.14 mm	+538.23 k	+88.8%
Geode Capital Management	6.12 mm	+505.02 k	+9.0%
Nuveen Asset Management	1.03 mm	+454.81 k	+78.6%
STT State Street	6.61 mm	+430.74 k	+7.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ME insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
30 Nov 23	Kathy L Hibbs	Class A Common Stock	Sell	Dispose S	No	Yes	0.8756	38,548	33.75 k	1,280,349
30 Nov 23	Kathy L Hibbs	Class A Common Stock	Option exercise	Acquire M	No	No	0.42	38,548	16.19 k	1,318,897
30 Nov 23	Kathy L Hibbs	Stock Option Class A Common Stock	Option exercise	Dispose M	No	No	0.42	38,548	16.19 k	424,031
20 Nov 23	Joseph Anthony Selsavage	Class A Common Stock	Payment of exercise	Dispose F	No	No	0.91	6,208	5.65 k	1,316,054
20 Nov 23	William G Richards	Class A common Stock	Payment of exercise	Dispose F	No	No	0.91	5,695	5.18 k	665,037
20 Nov 23	Kathy L Hibbs	Class A Common Stock	Payment of exercise	Dispose F	No	No	0.91	4,627	4.21 k	1,280,349
16 Nov 23	Kathy L Hibbs	Class A Common Stock	Sell	Dispose S	No	Yes	0.7713	38,548	29.73 k	1,284,976
16 Nov 23	Kathy L Hibbs	Class A Common Stock	Option exercise	Acquire M	No	No	0.42	38,548	16.19 k	1,323,524
16 Nov 23	Kathy L Hibbs	Stock Option Class A Common Stock	Option exercise	Dispose M	No	No	0.42	38,548	16.19 k	462,579